Imugene (ASX:IMU) Accumulated Depreciation : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Imugene Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Imugene's quarterly accumulated depreciation increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$-0.34 Mil) but then stayed the same from Jun. 2023 (A$-0.34 Mil) to Dec. 2023 (A$0.00 Mil).

Imugene's annual accumulated depreciation increased from Jun. 2021 (A$-0.25 Mil) to Jun. 2022 (A$-0.43 Mil) but then stayed the same from Jun. 2022 (A$-0.43 Mil) to Jun. 2023 (A$-0.34 Mil).

Imugene Accumulated Depreciation Historical Data

The historical data trend for Imugene's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imugene Accumulated Depreciation Chart

Imugene Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accumulated Depreciation

Get a 7-Day Free Trial

-0.07

-0.15

-0.25

-0.43

-0.34

Imugene Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accumulated Depreciation	Get a 7-Day Free Trial															-	-0.43	-	-0.34	-

Imugene Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Imugene Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Imugene's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Imugene (ASX:IMU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Imugene Ltd (ASX:IMU) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

IUGNF:USA

Address

4-6 Bligh Street, Suite 12.01, Level 12, Sydney, NSW, AUS, 2000

Website

https://www.imugene.com

Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its product includes HER-Vaxx,PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being the Research and Development of oncolytic immunotherapies.

Imugene (ASX:IMU) Headlines

No Headlines